Cancer News


Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Giving the two immunotherapies ipilimumab and nivolumab simultaneously yielded better treatment responses than ipilimumab alone in patients with advanced melanoma who received no prior treatment, ...

Tue 21 Apr 15 from Medical Xpress

Other sources: Medical Xpress, Reuters, HealthCanal (2), MedPageToday (2), WebMD show all (7) »

Woman's brain tumor turns out to be embryonic twin

Tumors are generally a pretty bad thing, and brain tumors doubly so. 26-year-old Indiana resident Yamini Karanam was understandably concerned when a tumor was detected in her brain, but what ...

Sat 25 Apr 15 from Geek.com

Other sources: Geek.com, Discovery.com show all (3) »

Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response

A newly developed technology for simultaneously comparing response to multiple cancer drugs or combinations while a tumor is still in a patient's body has been shown to accurately predict systemic ...

Wed 22 Apr 15 from Medical Xpress

Other sources: Medical Xpress, FOXNews, HealthCanal show all (4) »

Eligible for breast conserving therapy, many still choose mastectomy

No approved targeted therapies exist to treat triple-negative breast cancer, but new chemotherapeutic treatment strategies are helping shrink tumors so that less breast tissue needs to be removed ...

Thu 23 Apr 15 from Medical Xpress

Other sources: Medical Xpress, WebMD, Health News show all (4) »

Drug shows early promise for advanced lung cancer

(HealthDay)—A new drug that boosts the immune system's cancer-fighting potential is showing early promise for some patients with advanced lung cancer.

Mon 20 Apr 15 from Medical Xpress

Other sources: Medical Xpress (2), FOXNews, Reuters (3), MedPageToday, HealthCanal (2) show all (7) »

Sofosbuvir/daclatasvir combination effective treatment for difficult-to-treat hep C patients

Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 ...

Sat 25 Apr 15 from Medical Xpress

Other sources: Medical Xpress (4) show all (2) »

Cancer mutations often misidentified in the clinic

Examining normal tissue as well as tumours gives physicians a better shot at choosing effective therapies.

Wed 15 Apr 15 from Nature News

Other sources: Nature News, Medical Xpress, ScienceNews, FOXNews, Reuters show all (9) »

Sex, disease resistance linked to elite aging in study of oldest-living dogs

To understand what it takes to live to be 100, scientists in the field of aging research have been enlisting help from the oldest-living humans. But a powerful observation - when it comes to ...

Fri 24 Apr 15 from Phys.org

Other sources: Phys.org, Laboratory Equipment show all (3) »

First guidelines from the American Thyroid Association: Managing thyroid nodules, cancer in children

Previous guidelines from the American Thyroid Association (ATA) for evaluating and managing thyroid nodules and thyroid cancers targeted adults. Recognizing the potential differences in clinical ...

Wed 22 Apr 15 from Medical Xpress

Other sources: Medical Xpress, HealthCanal, MedPageToday (2), AlphaGalileo show all (5) »

US breast cancer cases could rise 50 percent by 2030

(HealthDay)—The number of U.S. women diagnosed with breast cancer could rise by as much as 50 percent within the next 15 years, according to new government predictions.

Mon 20 Apr 15 from Medical Xpress

Other sources: Medical Xpress, L.A. Times, MedPageToday show all (4) »

Show more »